Drug name - Amturnide

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8183295 NOVARTIS Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic May, 2023

(7 months from now)

More Information on Dosage
Strength Dosage Availability
EQ 150MG BASE;EQ 5MG BASE;12.5MG TABLET;ORAL Discontinued
EQ 300MG BASE;EQ 5MG BASE;12.5MG TABLET;ORAL Discontinued
EQ 300MG BASE;EQ 5MG BASE;25MG TABLET;ORAL Discontinued
EQ 300MG BASE;EQ 10MG BASE;12.5MG TABLET;ORAL Discontinued
EQ 300MG BASE;EQ 10MG BASE;25MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.